Biocatch

BioCatch is an Israeli fintech company founded in 2011 by Avi Turgeman and Uri Rivner. The company specializes in behavioral biometrics — technology that analyzes how users interact with digital devices (mouse movements, keystroke dynamics, smartphone grip angles) to detect fraud and verify identity.

BioCatch's primary product is a behavioral biometrics platform aimed primarily at banks and financial institutions. The platform monitors behavioral signals in real time as users perform actions such as logging in, transferring funds, or opening new accounts, and identifies anomalies that may indicate fraud, account takeover, or social engineering attacks. The primary buyers are retail banking organizations and fraud-prevention teams at large banks.

BioCatch operates in the financial fraud detection space using behavioral biometrics — an approach that differentiates it from traditional identity verification providers relying on passwords, OTPs, or physical biometrics (fingerprints, facial recognition). In 2022, BioCatch completed a $100 million funding round led by Darwin Equity Partners, which valued the company at over one billion dollars and established it as a unicorn.

BioCatch's R&D center is based in Tel Aviv. The founders, Avi Turgeman and Uri Rivner, are Israeli, and the company's core technical development has remained in Israel. BioCatch typically recruits in Israel for research, data science, and machine learning roles.